Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.

Authors : Gorin L L; Fauchier L L; Nonin E E; de Labriolle A A; Haguenoer K K; Cosnay P P; Babuty D D; Charbonnier B B;

Affiliations : Laurent Fauchier, MD, Service de Cardiologie B et Laboratoire d'Electrophysiologie Cardiaque, Pole Coeur Thorax Vasculaire Hémostase, Centre Hospitalier Universitaire Trousseau, 37044 Tours, France, Tel.: +33 2 47 47 46 50, Fax: +33 2 47 47 59 19, E-mail: lfau@med.univ-tours.fr.

Journal : N/A   (2010)

Related Links: Pubmed | Publisher website

Progressive endothelial damage revealed by multilevel von Willebrand factor plasma concentrations in atrial fibrillation patients

Authors :

Affiliations : Unité de Neurocardiologie EA4612, Université Lyon 1, Lyon F-69008, France Physiology Department, University of Medicine and Pharmacy of Targu Mures, Targu Mures, Romania Hospices Civils de Lyon, Hôpital Louis Pradel, Service de Rythmologie, 28 Avenue du Doyen Lépine, 69500 Bron Cedex, Lyon, France Hospices Civils de Lyon, Hôpital Edouard Herriot, Laboratoire d'hémostase, Lyon, France

Journal : N/A   (2013)

Related Links: Pubmed | Publisher website